SP-102

· Semnur Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SP-102, covering 2022-01-13 to 2022-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 [Phase 2]